Interview with Carlos de Sousa, CEO of Immunicum
28 Mar 2017 08:436650
Carlos de Sousa explains the uniqueness and potential of Intuvax, what to expect during the next 12 months and why Immunicum is an attractive investment opportunity.
Read more
LIVE00:00/00:00
- 51:40
Report presentation and Q&A with CEO Carlos de Sousa, Immunicum, 17 February 2017
Viewers had the opportunity to ask questions in an interesting Q&A session after Carlos de Sousa, CEO of Immunicum, presented corporate developments and financial results. The discussion also included Klas Palin, Life Science analyst, and Chief Editor, Eddie Palmgren.
06950 - 21:10
Immunicum, VD Carlos de Sousa presenterar på Immunonkologieventet 21 september
01610 - 26:29
Immunicum, vd Carlos de Sousa presenterar på Småbolagsdagen 12 juni 2017
02600 - 31:46
Immunicums VD Carlos de Sousa presenterar på Investor After Work 4 april
01510 - 27:33
Immunicum VD Carlos de Sousa presenterar på Fight cancer 10 mars
01710
Add a comment...